Knockdown of aberrantly expressed nuclear localized decorin attenuates tumour angiogenesis related mediators in oral cancer progression model in vitro

Head and Neck Oncology

Volumn 4, Issue 1, 2012, Pages

  Dil, Nyla ^a,b,c   Banerjee, Abhijit G ^a,d  

^a Departments of Medical Microbiology and Infectious Diseases   (Canada)

^b Immunology   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d Center for Genomic Bio Medicine and Res Inst   (India)

Author keywords

ANG1; Angiogenesis; CXCR; Decorin; Functional genomics; IL 8; MMP9; Oral cancer; VEGF

Indexed keywords

ANGIOTENSIN I; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; DECORIN; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 8; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN 189;

ANGIOGENESIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME INDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUTH CANCER; MOUTH MUCOSA; MULTIPLEX POLYMERASE CHAIN REACTION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DECORIN; DISEASE PROGRESSION; GENE KNOCKDOWN TECHNIQUES; HEAD AND NECK NEOPLASMS; HUMANS; MATRIX METALLOPROTEINASE 9; MOUTH NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, INTERLEUKIN-8; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84859715676     PISSN: None     EISSN: 17583284     Source Type: Journal    
DOI: 10.1186/1758-3284-4-11     Document Type: Article

References (46)

1. National Cancer Database report on cancer of the head and neck: 10-year update. Cooper JS, Porter K, Mallin K, Hoffman HT, Weber RS, Ang KK, Gay EG, Langer CJ, Head Neck 2009 31 748 758 10.1002/hed.21022 19189340
2. Cancer statistics. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ, CA Cancer J Clin 2008 58 71 96 10.3322/CA.2007.0010 18287387
3. Global cancer statistics, 2002. Parkin DM, Bray F, Ferlay J, Pisani P, CA Cancer J Clin 2005 55 74 108 10.3322/canjclin.55.2.74 15761078
4. Oral cavity cancer in developed and in developing countries: population-based incidence. de Camargo Cancela M, Voti L, Guerra-Yi M, Chapuis F, Mazuir M, Curado MP, Head Neck 2010 32 357 367 19644932
5. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Hanahan D, Folkman J, Cell 1996 86 353 364 10.1016/S0092-8674(00) 80108-7 8756718
6. Tumorigenesis and the angiogenic switch. Bergers G, Benjamin LE, Nat Rev Cancer 2003 3 401 410 10.1038/nrc1093 12778130
7. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D, Nat Cell Biol 2000 2 737 744 10.1038/35036374 11025665
8. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Ferrara N, Henzel WJ, Biochem Biophys Res Commun 1989 161 851 858 10.1016/0006-291X(89)92678-8 2735925
9. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW, Mol Endocrinol 1991 5 1806 1814 10.1210/mend-5-12-1806 1791831
10. Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Charnock-Jones DS, Sharkey AM, Rajput-Williams J, Burch D, Schofield JP, Fountain SA, Boocock CA, Smith SK, Biol Reprod 1993 48 1120 1128 10.1095/biolreprod48.5.1120 8481475
11. Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants. Neufeld G, Cohen T, Gitay-Goren H, Poltorak Z, Tessler S, Sharon R, Gengrinovitch S, Levi BZ, Cancer Metastasis Rev 1996 15 153 158 10.1007/BF00437467 8842486
12. Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma. Smith BD, Smith GL, Carter D, Sasaki CT, Haffty BG, J Clin Oncol 2000 18 2046 2052 10811669
13. Normalization of the vasculature for treatment of cancer and other diseases. Goel S, Duda DG, Xu L, Munn LL, Boucher Y, Fukumura D, Jain RK, Physiol Rev 2011 91 1071 1121 10.1152/physrev.00038.2010 21742796
14. Dancing to the tune of chemokines. Thelen M, Nat Immunol 2001 2 129 134 10.1038/84224 11175805
15. Chemokines. Rollins BJ, Blood 1997 90 909 928 9242519
16. The biology of chemokines and their receptors. Rossi D, Zlotnik A, Annu Rev Immunol 2000 18 217 242 10.1146/annurev.immunol.18.1.217 10837058
17. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG, Strieter RM, Science 1992 258 1798 1801 10.1126/science.1281554 1281554
18. Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma. Smith DR, Polverini PJ, Kunkel SL, Orringer MB, Whyte RI, Burdick MD, Wilke CA, Strieter RM, J Exp Med 1994 179 1409 1415 10.1084/jem.179.5.1409 7513008
19. Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis. Strieter RM, Kunkel SL, Arenberg DA, Burdick MD, Polverini PJ, Biochem Biophys Res Commun 1995 210 51 57 10.1006/bbrc.1995.1626 7537965
20. Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. Arenberg DA, Kunkel SL, Polverini PJ, Morris SB, Burdick MD, Glass MC, Taub DT, Iannettoni MD, Whyte RI, Strieter RM, J Exp Med 1996 184 981 992 10.1084/jem.184.3.981 9064358
21. Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization. Perollet C, Han ZC, Savona C, Caen JP, Bikfalvi A, Blood 1998 91 3289 3299 9558385
22. Inhibition of in vitro angiogenesis by platelet factor-4-derived peptides and mechanism of action. Jouan V, Canron X, Alemany M, Caen JP, Quentin G, Plouet J, Bikfalvi A, Blood 1999 94 984 993 10419890
23. Role of C-X-C chemokines as regulators of angiogenesis in lung cancer. Strieter RM, Polverini PJ, Arenberg DA, Walz A, Opdenakker G, Van Damme J, Kunkel SL, J Leukoc Biol 1995 57 752 762 7539029
24. Cxc chemokine receptor expression on human endothelial cells. Murdoch C, Monk PN, Finn A, Cytokine 1999 11 704 712 10.1006/cyto.1998.0465 10479407
25. Retinoic acid induces cells cultured from oral squamous cell carcinomas to become anti-angiogenic. Lingen MW, Polverini PJ, Bouck NP, Am J Pathol 1996 149 247 258 8686749
26. Fibrin induces IL-8 expression from human oral squamous cell carcinoma cells. Lalla RV, Goralnick SJ, Tanzer ML, Kreutzer DL, Oral Oncol 2001 37 234 242 10.1016/S1368-8375(00)00090-7 11287277
27. Aberrant expression and localization of decorin in human oral dysplasia and squamous cell carcinoma. Banerjee AG, Bhattacharyya I, Lydiatt WM, Vishwanatha JK, Cancer Res 2003 63 7769 7776 14633702
28. A role for aberrantly expressed nuclear localized decorin in migration and invasion of dysplastic and malignant oral epithelial cells. Dil N, Banerjee AG, Head Neck Oncol 2011 3 44 10.1186/1758-3284-3-44 21958730
29. Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines. Hu L, Crowe DL, Rheinwald JG, Chambon P, Gudas LJ, Cancer Res 1991 51 3972 3981 1713123
30. Transforming growth factor beta 1 dysregulation in a human oral carcinoma tumour progression model. Hsu S, Borke JL, Lewis JB, Singh B, Aiken AC, Huynh CT, Schuster GS, Caughman GB, Dickinson DP, Smith AK, et al. Cell Prolif 2002 35 183 192 10.1046/j.1365-2184.2002.00237.x 12027954
31. Tumor angiogenesis: therapeutic implications. Folkman J, N Engl J Med 1971 285 1182 1186 10.1056/NEJM197111182852108 4938153
32. Tumor angiogenesis. Petruzzelli GJ, Head Neck 1996 18 283 291 10.1002/(SICI)1097-0347(199605/06)18:3<283::AID-HED11>3.0.CO;2-C 8860771
33. The implications of angiogenesis for the biology and therapy of cancer metastasis. Fidler IJ, Ellis LM, Cell 1994 79 185 188 10.1016/0092-8674(94) 90187-2 7525076
34. Differential and regulated expression of C-X-C, C-C, and C-chemokines by human colon epithelial cells. Yang SK, Eckmann L, Panja A, Kagnoff MF, Gastroenterology 1997 113 1214 1223 10.1053/gast.1997.v113.pm9322516 9322516
35. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. Inoue K, Slaton JW, Eve BY, Kim SJ, Perrotte P, Balbay MD, Yano S, Bar-Eli M, Radinsky R, Pettaway CA, Dinney CP, Clin Cancer Res 2000 6 2104 2119 10815938
36. Coexpression of interleukin-8 receptors in head and neck squamous cell carcinoma. Richards BL, Eisma RJ, Spiro JD, Lindquist RL, Kreutzer DL, Am J Surg 1997 174 507 512 10.1016/S0002-9610(97)00165-7 9374226
37. Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Salcedo R, Ponce ML, Young HA, Wasserman K, Ward JM, Kleinman HK, Oppenheim JJ, Murphy WJ, Blood 2000 96 34 40 10891427
38. IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. Li A, Dubey S, Varney ML, Dave BJ, Singh RK, J Immunol 2003 170 3369 3376 12626597
39. Neutrophil elastase induces IL-8 gene transcription and protein release through p38/NF-{kappa}B activation via EGFR transactivation in a lung epithelial cell line. Kuwahara I, Lillehoj EP, Lu W, Singh IS, Isohama Y, Miyata T, Kim KC, Am J Physiol Lung Cell Mol Physiol 2006 291 407 L416 10.1152/ajplung.00471. 2005 16632517
40. Injury is a major inducer of epidermal innate immune responses during wound healing. Roupe KM, Nybo M, Sjobring U, Alberius P, Schmidtchen A, Sorensen OE, J Invest Dermatol 2010 130 1167 1177 10.1038/jid.2009.284 19727116
41. Matrix metalloproteinases: multifunctional contributors to tumor progression. McCawley LJ, Matrisian LM, Mol Med Today 2000 6 149 156 10.1016/S1357-4310(00)01686-5 10740253
42. Chemotherapeutic drugs-more really is not better. Fidler IJ, Ellis LM, Nat Med 2000 6 500 502 10.1038/74969 10802697
43. Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Nor JE, Christensen J, Mooney DJ, Polverini PJ, Am J Pathol 1999 154 375 384 10.1016/S0002-9440(10)65284-4 10027396
44. Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells. Tran J, Rak J, Sheehan C, Saibil SD, LaCasse E, Korneluk RG, Kerbel RS, Biochem Biophys Res Commun 1999 264 781 788 10.1006/bbrc.1999.1589 10544009
45. Signaling and functions of angiopoietin-1 in vascular protection. Brindle NP, Saharinen P, Alitalo K, Circ Res 2006 98 1014 1023 10.1161/01.RES. 0000218275.54089.12 16645151
46. Angiopoietin-1 promotes endothelial cell proliferation and migration through AP-1-dependent autocrine production of interleukin-8. Abdel-Malak NA, Srikant CB, Kristof AS, Magder SA, Di Battista JA, Hussain SN, Blood 2008 111 4145 4154 10.1182/blood-2007-08-110338 18252863